03 NOV 2020

UDG Healthcare plc (LSE: UDG), a leading international healthcare services provider, will be announcing its full year results for year ended 30 September 2020 on the morning of Tuesday 24 November 2020.

Brendan McAtamney, Chief Executive Officer, Nigel Clerkin, Chief Financial Officer, and Ryan Quigley, Chief Operating Officer will host a presentation for analysts and investors to discuss the company's full year results and provide an update on each of the Group's divisions, followed by a Q&A.



Tuesday 24 November 2020

Presentation times:

Results presentation will be available to watch on demand from 7.00am, via a pre-recorded video webcast


Live Q&A will commence at 9.00am, available via audio webcast and conference call.

Q&A conference call registration link:


Q&A webcast registration link:


Please note: If you wish to ask a question during the live Q&A at 9.00am, please dial into the conference call, as participants on the webcast will be in listen-only mode and therefore unable to ask questions.

It is suggested participants dial-in to the Q&A at least 15 minutes prior in order to ensure a timely start to the briefing.

For further information, please contact:

UDG Healthcare plc
Keith Byrne
Head of Investor Relations, Strategy & Corporate Communications
Tel: +353-1-468-9000

Lisa Kavanagh / Jack Hickey / Eavan Gannon / Ella Morris

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a FTSE 250 global leader in the healthcare advisory, communications, commercial, clinical and packaging services industries. UDG employs 9,000 people across operations in 29 countries, delivering services in over 50 countries.

Operating across two divisions, Ashfield and Sharp, UDG provides outsourced services which enable over 300 healthcare companies from large pharmaceutical to small biotech to bring their products to market.

Ashfield is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across three business areas: Advisory, Communications and Commercial & Clinical. The division focuses on supporting patients to access and adhere to their medications and educating and communicating effectively with healthcare professionals and patients on these products at all stages of the product life cycle. Ashfield provides strategic consulting, advisory services, patient solutions, scientific and creative communications, PR, on-demand advertising services, field and contact centre sales teams, and medical information and event management services.

Sharp is a global leader in contract commercial packaging, clinical, manufacturing and technology services for the pharmaceutical and biotechnology industries, operating from eight state-of-the-art facilities in the US and Europe.

For more information, please go to: www.udghealthcare.com